← Leaderboards
Uwe D. Staerz
National Jewish Health
$9,517,095
Attributed
$9,517,095
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$9,517,095 · 8
By mechanism
R44$4,344,007 · 2
R01$3,166,789 · 2
R43$1,839,121 · 3
P01$167,178 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- G Scott Worthen$17,039,709
- Terry A Potter$6,252,906
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseCd8b1 GeneCellsBaseDesignAllogenicUnited States Food And Drug AdministrationAdverse EffectsProtocols DocumentationOrgan TransplantationVectorTechnologyImmuneCytotoxic T LymphocyteTransplantationIn VivoLeukocyte Activation /TransformationAntibody EngineeringEngineeringTissuesScientistMhc Class I AntigenImmune ResponseSurface
Grant awards (23)
Protection of Hepatocyte Transplants by Engineered Veto$696,116
R44 · FY2011 · DK · contact PI
Protection of Hepatocyte Transplants by Engineered Veto$651,668
R44 · FY2010 · DK · contact PI
Protection of Hepaticyte Transplants by Engineered Veto$186,145
R43 · FY2009 · DK · contact PI
Protecting Pancreatic Islet Grafts from Rejection$998,068
R44 · FY2008 · DK · contact PI
Veto-ing the Rejection of Allogeneic HSCs$300,000
R43 · FY2008 · AI · contact PI
Accessory Cells for Immature T Lymphocytes$285,143
R01 · FY2008 · HD · contact PI
Protection of Hepaticyte Transplants by Engineered Veto$186,145
R43 · FY2008 · DK · contact PI
Protecting Pancreatic Islet Grafts from Rejection$998,749
R44 · FY2007 · DK · contact PI
Veto-ing the Rejection of Allogeneic HSCs$300,001
R43 · FY2007 · AI · contact PI
Accessory Cells for Immature T Lymphocytes$290,962
R01 · FY2007 · HD · contact PI
Protecting Pancreatic Islet Grafts from Rejection$999,406
R44 · FY2006 · DK · contact PI
Accessory Cells for Immature T Lymphocytes$299,652
R01 · FY2006 · HD · contact PI
Protecting Pancreatic Islet Grafts from Rejection$433,415
R43 · FY2005 · DK
Accessory Cells for Immature T Lymphocytes$306,864
R01 · FY2005 · HD
Protecting Pancreatic Islet Grafts from Rejection$433,415
R43 · FY2004 · DK
Accessory Cells for Immature T Lymphocytes$299,376
R01 · FY2004 · HD
ACCESSORY CELLS FOR IMMATURE T-LYMPHOCYTES$296,553
R01 · FY2002 · HD
INDUCTION OF SPECIFIC IMMUNE TOLERANCE$281,723
R01 · FY2002 · AI
ACCESSORY CELLS FOR IMMATURE T-LYMPHOCYTES$287,917
R01 · FY2001 · HD
INDUCTION OF SPECIFIC IMMUNE TOLERANCE$273,516
R01 · FY2001 · AI
ACCESSORY CELLS FOR IMMATURE T-LYMPHOCYTES$279,533
R01 · FY2000 · HD
INDUCTION OF SPECIFIC IMMUNE TOLERANCE$265,550
R01 · FY2000 · AI
DEVELOPMENTAL REGULATION AND FUNCTIONAL CAPACITY OF FETAL LYMPHOCYTES$167,178
P01 · FY2000 · AI